Cargando…
Reactions related to asparaginase infusion in a 10-year retrospective cohort
INTRODUCTION: Although it is an essential component of the treatment of acute lymphoid leukemia in children, asparaginase causes adverse reactions that sometimes make it impossible to use it fully. Hypersensitivity reactions are the most frequent and may lead to early discontinuation of treatment. T...
Autores principales: | Santos, Amanda Cabral dos, Land, Marcelo Gerardin Poirot, Silva, Nathalia Peroni da, Santos, Kelly Oliveira, Lima-Dellamora, Elisangela da Costa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693393/ https://www.ncbi.nlm.nih.gov/pubmed/29150106 http://dx.doi.org/10.1016/j.bjhh.2017.08.002 |
Ejemplares similares
-
L‐asparaginase doses number as a prognostic factor in childhood acute lymphoblastic leukemia: A survival analysis study
por: dos Santos, Amanda Cabral, et al.
Publicado: (2021) -
Translation, transcultural adaptation and validation to Brazilian Portuguese of tools for adverse drug reaction assessment in children
por: da Costa Lima, Elisangela, et al.
Publicado: (2021) -
Recombinant L-Asparaginase from Zymomonas mobilis: A Potential New Antileukemic Agent Produced in Escherichia coli
por: Einsfeldt, Karen, et al.
Publicado: (2016) -
Multisystem inflammatory syndrome drug treatment in countries with different income profiles: a scoping review
por: Nagem Lopes, Luis Phillipe, et al.
Publicado: (2023) -
Correction: Recombinant L-Asparaginase from Zymomonas mobilis: A Potential New Antileukemic Agent Produced in Escherichia coli
por: Einsfeldt, Karen, et al.
Publicado: (2016)